Fatal TRALI associated with neutrophil antibodies in a recipient of pre-storage leukocyte-reduced blood components

Internal Medicine

Volumn 48, Issue 16, 2009, Pages 1429-1431

  Ishii, Kazuyoshi ^a   Kadota, Eiji ^a   Shimizu, Michiomi ^a   Nomura, Shosaku ^a  

^a Kishiwada City Hospital   (Japan)

Author keywords

Autoimmune neutropenia; Neutrophil antibodies; Transfusion related acute lung injury (TRALI); Universal prestorage leukoreduction

Indexed keywords

GRANULOCYTE ANTIBODY; HYDROCORTISONE; METHYLPREDNISOLONE;

ADULT; ANAMNESIS; ANTIBODY DETECTION; APLASTIC ANEMIA; APNEA; ARTICLE; AUTOIMMUNE DISEASE; BLOOD STORAGE; CASE REPORT; CLINICAL FEATURE; ECHOCARDIOGRAPHY; ENDOTHELIUM LESION; ERYTHROCYTE TRANSFUSION; FATALITY; HEART ARREST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOCYTE AGGREGATION; LUNG EMBOLISM; MACROCYTIC ANEMIA; MALE; MYXEDEMA; NEUTROPENIA; ORGANIZING PNEUMONIA; PRESTORAGE LEUKOREDUCTION; RECIPIENT; TRANSFUSION RELATED ACUTE LUNG INJURY;

ACUTE LUNG INJURY; CELL AGGREGATION; ERYTHROCYTE TRANSFUSION; FATAL OUTCOME; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; NEUTROPHIL INFILTRATION; NEUTROPHILS;

EID: 70349515207     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.2305     Document Type: Article

References (14)

1. Holness L, Knippen MA, Simmons L, Lachenbruch PA. Fatalities caused by TRALI. Transfus Med Rev 18: 184-188, 2004.
2. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 25: 573-577, 1985.
3. Fatalities Reported to FDA Following Blood Collection and Transfusion [Internet]. Silver Spring, MD: U.S. Food and Drug Administration; 2009 March 4 - [cited 2009 March 28]; Available from: http://www.fda.gov/cber/ blood/fatal08.htm
4. Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 44: 1774-1789, 2004.
5. Dry SM, Bechard KM, Milford EL, Churchill WH, Benjamin RJ. The pathology of transfusion-related acute lung injury. Am J Clin Pathol 112: 216-221, 1999.
6. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 136: 788-799, 2007.
7. Kawahito K, Kobayashi E, Ohmori M, et al. Enhanced responsiveness of circulatory neutrophils after cardiopulmonary bypass: increased aggregability and superoxide producing capacity. Artif Organs 24: 37-42, 2000.
8. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 101: 454-462, 2003.
9. jSilliman CC, Curtis BR, Kopko PM, et al. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 109: 1752-1755, 2007.
10. Boxer LA, Greenberg MS, Boxer GJ, Stossel TP. Autoimmune neutropenia. N Engl J Med 293: 748-753, 1975.
11. Yazer MH, Podlosky L, Clarke G, Nahirniak SM. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion 44: 10-15, 2004.
12. Seftel MD, Growe GH, Petraszko T, et al. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness. Blood 103: 333-339, 2004.
13. Muniz M, Sheldon S, Schuller RM, et al. Patient-specific transfusion-related acute lung injury. Vox Sang 94: 70-73, 2008.
14. Knop S, Bux J, Kroeber SM, et al. Fatal immune-mediated pancytopenia and a TRALI-like syndrome associated with high titers of recipient-type antibodies against donor-derived peripheral blood cells after allogeneic BMT following dose reduced conditioning. Haematologica 89: e37-e38, 2004.